SpaceX IPO Tests Wall Street’s Valuation Models
SpaceX’s planned public debut is raising questions about how investors should value companies that combine commercial technology, defense relevance and infrastructure-like importance. The company does not fit neatly into familiar categories such as rocket manufacturer, satellite internet provider or government contractor.
Its IPO filing shows why. SpaceX said it was the primary launch provider for the U.S. government in 2025, handling most national security launch missions and all NASA crew and cargo flights to the International Space Station. About one-fifth of its 2025 revenue came from federal agencies. At the same time, its Starlink network had 10.3 million subscribers as of March 31, more than twice the prior year’s total, and operated 10,000 low-Earth-orbit satellites.
The article frames SpaceX as part of a broader “strategic tech” category: companies whose value may reflect not only growth, but also their role in essential government, military and communications systems. Unlike traditional defense contractors, SpaceX has significant commercial exposure and potentially stronger growth prospects. Unlike regulated utilities, it provides infrastructure without the same level of rate-setting oversight.
A comparison is made to Palantir, which trades at a high earnings multiple partly because its software is embedded in government operations while also growing faster than conventional defense firms. Other companies, including Anduril, OpenAI and Anthropic, may face similar investor questions if their technologies become critical infrastructure.
The article also notes potential limits to this premium. As companies become more important to national interests, they may attract closer government scrutiny. That could include procurement rules, cybersecurity obligations, pricing pressure, antitrust review or broader regulation.
For investors, the SpaceX IPO may become a test case for how public markets price strategic importance alongside revenue growth, commercial demand and future regulatory risk. The outcome could influence valuations for similar strategic companies.